InsidersTradesSigma
Kato (Hong Kong) Holdings Ltd.: insider trades · Hong Kong · HKEX
HKEX:kato-hong-kong-holdings-ltdHK·HKEXMcap 475M€Healthcare
Discover the full directors' dealings record of Kato (Hong Kong) Holdings Ltd., a publicly traded company based in Hong Kong. Shares are listed on HK HK, under the authority of HKEX. Operating in the Healthcare sector, Kato (Hong Kong) Holdings Ltd. has logged 5 insider filings. Market capitalisation: €475m. The latest transaction was filed on 10 April 2026 — Purchase. Among the most active insiders: Ngai Shi Shing Godfrey. All data is openly available.
5
Insider Decl.
0
Thresholds
€197,811
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
0.47 €
Analyst consensus
Income statement
Revenue317.1 M€
Gross profit296.8 M€94% margin
Net income21.9 M€6.8% margin
Valuation
PER (trailing)23.8x
P/Book1.1x
Beta0.02
Balance sheet & cash
Market cap475.0 M€
Total debt333.0 M€
Free Cash Flow71.1 M€
Debt / Equity67%
Profitability & ownership
ROE5.2%
ROA5.3%
% insiders71.1%
% institutions0.0%
Last declaration on 10 April 2026
Declarations5 total
Executives●Purchase7HKEX
€35,475668,000 shares@ €0.05310.0075% mcap17.9% of flow
ShareXHKG
HKEX:DA20260409E00397·
Ideal exit: 3 Jan 2027 (T+270)
Executives●Purchase8HKEX
€49,463952,000 shares@ €0.0520.010% mcap25.0% of flow
ShareXHKG
HKEX:DA20260408E00056·
Ideal exit: 28 Dec 2026 (T+270)
Executives●Purchase12HKEX
€97,7701,908,000 shares@ €0.05120.021% mcap49.4% of flow
ShareXHKG
HKEX:DA20260401E00231·
Ideal exit: 26 Dec 2026 (T+270)
Executives●Purchase4HKEX
€7,376148,000 shares@ €0.04980.0016% mcap3.7% of flow
ShareXHKG
HKEX:DA20260330E00189·
Ideal exit: 22 Dec 2026 (T+270)
Executives●Purchase4HKEX
€7,727156,000 shares@ €0.04950.0016% mcap3.9% of flow
ShareXHKG
HKEX:DA20260320E00376·
Ideal exit: 14 Dec 2026 (T+270)
5 of 5 declarations